Clinical Trials Browser

Phase 2 × Losartan × 90 days × Clear all

NCT07265739 2026-05-06

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Phase 2 Recruiting

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT05077800 2026-04-13

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma